Invention Grant
US07919078B2 Recombinant interferon α2 (IFNα2) mutants and methods of use thereof
有权
重组干扰素α2（IFNα2）突变体及其使用方法
- Patent Title: Recombinant interferon α2 (IFNα2) mutants and methods of use thereof
- Patent Title (中): 重组干扰素α2（IFNα2）突变体及其使用方法
-
Application No.: US11969319Application Date: 2008-01-04
-
Publication No.: US07919078B2Publication Date: 2011-04-05
- Inventor: Gideon E Schreiber , Laila C. Roisman , Diego Jaitin , Eyal Kalie
- Applicant: Gideon E Schreiber , Laila C. Roisman , Diego Jaitin , Eyal Kalie
- Applicant Address: IL Rehovot
- Assignee: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
- Current Assignee: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
- Current Assignee Address: IL Rehovot
- Agency: Winston & Strawn LLP
- Main IPC: A61K38/21
- IPC: A61K38/21 ; C07K14/56
Abstract:
The present invention provides IFNα2 mutants and active fragments, analogs, derivatives, and variants thereof, nucleotide molecules encoding same, pharmaceutical compositions containing the same, and methods utilizing the same for treating cancer, infectious diseases, and autoimmune diseases.
Public/Granted literature
- US20080166319A1 RECOMBINANT INTERFERON ALPHA2 (IFNALPHA2) MUTANTS AND METHODS OF USE THEREOF Public/Granted day:2008-07-10
Information query
IPC分类:
